We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+10.09%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$6.26B
AUM Growth
+$363M
Cap. Flow
-$130M
Cap. Flow %
-2.08%
Top 10 Hldgs %
19.16%
Holding
2,624
New
54
Increased
718
Reduced
1,361
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Financials 14.02%
3 Healthcare 13.38%
4 Consumer Discretionary 9.94%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRC icon
1701
NRC Health Common Stock
NRC
$456M
$275K ﹤0.01%
4,166
GABC icon
1702
German American Bancorp
GABC
$1.91B
$275K ﹤0.01%
7,712
-459
-6% -$15.4K
OSW icon
1703
OneSpaWorld
OSW
$2.7B
$274K ﹤0.01%
16,300
-844
-5% -$13.3K
CHK
1704
DELISTED
Chesapeake Energy Corporation
CHK
$274K ﹤0.01%
1,662
+67
+4% +$13.5K
DBX icon
1705
Dropbox
DBX
$7.31B
$274K ﹤0.01%
15,298
-285
-2% -$5.37K
CARO
1706
DELISTED
Carolina Financial Corp.
CARO
$274K ﹤0.01%
6,331
MRNA icon
1707
Moderna
MRNA
$25.4B
$273K ﹤0.01%
13,979
-67
-0.5% -$1.19K
FARO
1708
DELISTED
Faro Technologies
FARO
$273K ﹤0.01%
5,429
MAXR
1709
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$270K ﹤0.01%
17,236
-314
-2% -$3.26K
SRI icon
1710
Stoneridge
SRI
$197M
$268K ﹤0.01%
9,155
-465
-5% -$14.3K
NWS icon
1711
News Corp Class B
NWS
$17.7B
$268K ﹤0.01%
18,476
+44
+0.2% +$606
VNDA icon
1712
Vanda Pharmaceuticals
VNDA
$314M
$268K ﹤0.01%
16,330
-857
-5% -$13K
PFBC icon
1713
Preferred Bank
PFBC
$1.26B
$267K ﹤0.01%
4,451
-259
-5% -$14.2K
VRTS icon
1714
Virtus Investment Partners
VRTS
$1.12B
$267K ﹤0.01%
2,197
-116
-5% -$12.9K
BERY
1715
DELISTED
Berry Global Group, Inc.
BERY
$267K ﹤0.01%
6,130
-66
-1% -$2.62K
ELAN icon
1716
Elanco Animal Health
ELAN
$11.1B
$267K ﹤0.01%
9,066
+30
+0.3% +$815
ENVA icon
1717
Enova International
ENVA
$6.48B
$267K ﹤0.01%
11,096
SAGE
1718
DELISTED
Sage Therapeutics
SAGE
$267K ﹤0.01%
3,695
-20
-0.5% -$2.46K
ANIK icon
1719
Anika Therapeutics
ANIK
$295M
$267K ﹤0.01%
5,141
EXTR icon
1720
Extreme Networks
EXTR
$3.2B
$267K ﹤0.01%
36,168
-778
-2% -$5.46K
CMTL icon
1721
Comtech Telecommunications
CMTL
$52.1M
$266K ﹤0.01%
7,508
-464
-6% -$16K
ANDE icon
1722
Andersons Inc
ANDE
$2.21B
$266K ﹤0.01%
10,524
RGR icon
1723
Sturm, Ruger & Co
RGR
$600M
$265K ﹤0.01%
5,633
ACCO icon
1724
Acco Brands
ACCO
$399M
$265K ﹤0.01%
28,294
+1,196
+4% +$11.3K
CCF
1725
DELISTED
Chase Corporation
CCF
$264K ﹤0.01%
2,231
-131
-6% -$15.2K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2019 Portfolio in Review

As of Q4 2019, Metropolitan Life Insurance Company (MetLife) held 2,624 positions worth $6.26B, up 6.2% from $5.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2019 filing shows 54 new, 718 increased, 1,361 reduced and 88 closed positions. Its largest new stake was SolarEdge: 12,469 shares worth $1.19M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2019 buy was SolarEdge: 12,469 shares worth $1.19M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $35.2M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2019 reduction was Apple, cutting an estimated $8.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited iShares 20+ Year Treasury Bond ETF in Q4 2019, selling an estimated $143M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 19% of its $6.26B portfolio in Q4 2019.
  • Metropolitan Life Insurance Company (MetLife) opened 54 new positions and closed 88 in Q4 2019.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.2% quarter-over-quarter to $6.26B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2019, filed 14 Feb 2020.